Shares of Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) traded down 4.3% during mid-day trading on Friday . The company traded as low as $1.11 and last traded at $1.12. 88,090 shares traded hands during trading, an increase of 31% from the average session volume of 67,097 shares. The stock had previously closed at $1.17.
Cardiol Therapeutics Trading Down 5.9 %
The stock’s fifty day moving average price is $1.24 and its 200-day moving average price is $1.57.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
Featured Stories
- Five stocks we like better than Cardiol Therapeutics
- How to find penny stocks to invest and trade
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Where to Find Earnings Call Transcripts
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Buy P&G Now, Before It Sets A New All-Time High
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
